The year ahead: What does 2021 hold in store for real estate investors?
Moving into 2021, “this too shall pass” seems to be the resounding message among real estate investors.
January 1, 2021: Vol. 33, Number 1
$275.00
Add To Cart
From the Current Issue
Hidden gems: A look at investment opportunities in global secondary markets
The hunt for yield and portfolio diversification has sparked institutional interest in global secondary markets in recent years, and potential shifts in behavior related to the COVID-19 pandemic could further strengthen those strategies.
Navigating turbulent times: Real estate portfolio construction and risk management during a downturn
In the current environment, real estate is poised to play a critical role in institutional investors’ portfolios. Real estate, however, is not without risk.
Manufacturing trends: Are reshoring and nearshoring of manufacturing imminent and inevitable?
The coronavirus pandemic has once again brought to the fore the “manufacturing reshoring and nearshoring” debate.
A shift from defense to offense: What the real estate industry is talking about
The LP-GP 4x4 Virtual Roundtables for the editorial board members of Institutional Real Estate Americas continue to be a way for the industry to dialogue about the issues and concerns that are front and center.
Retailers find ways to adapt to COVID-19
Retail real estate has taken a beating in the COVID-19 era, but some segments are faring better than others.
Homebuilding supported by de-urbanization trend
Homebuilding has fared well during the pandemic, driven in part by a trend toward de-urbanization amid COVID-19.
Job growth slows in November
Amid a surge in COVID-19 cases, total nonfarm payroll employment increased by only 245,000 jobs in November, according to the Bureau of Labor Statistics.
Pension funds issue RFPs for consulting services
Several public pension funds have launched consultant searches in advance of contract expirations.
Life sciences REIT raises $1.7b in new funding round
IQHQ, a life sciences REIT, has raised $1.7 billion in a funding round of new equity to support expansion of the company’s growing portfolio of properties in premier life sciences markets.
Year-end slowdown: Coronavirus pandemic puts the brakes on fundraising
As of early December, preliminary data showed only four fund closings, raising approximately $4.6 billion.